baber/WOPTO huggingface dataset:
Patent AU-2021203782-A1 (AU)
Title: Systems and methods for multitasking on an electronic device with a touch-sensitive display
Inventor: CHAUDHRI IMRAN A
IPC: G06F3/0482
Filed: 2021-06-08
Abstract: Systems and methods for multitasking using touch-sensitive devices are disclosed 
herein. In one aspect, a method includes: displaying, on a touch-sensitive display ("TSD") of a 
5 device, first and second applications such that the first and second applications occupy 
substantially all of the TSD and are separated at a border between the first and second 
applications. The method further includes: detecting a swipe gesture at the second application, 
the swipe gesture moving in a direction that is substantially parallel to the border. In response to 
detecting the swipe gesture, the method includes: determining whether the swipe gesture satisfies 
0 a threshold. Upon determining that the swipe gesture satisfies the threshold, the method includes: 
replacing the second application with an application selector that includes a plurality of 
selectable affordances corresponding to applications available on the device, the application 
selector being displayed in an area of the TSD previously occupied by the second application.
Patent AU-2021203783-A1 (AU)
Title: Novel CD47 Monoclonal Antibodies and Uses Thereof
Inventor: WANG ZHENGYI
IPC: C07K16/18
Filed: 2021-06-08
Abstract: The present invention provides novel CD47 antibodies or immunologically active 
fragments thereof that have low immunogenicity in humans and cause low or no level of red 
blood cell depletion or hemagglutination, as well as pharmaceutical compositions containing 
such antibodies that can be used for treatment of diseases mediated by CD47 or inhibition of 
phagocytosis or platelet aggregation.
Patent AU-2021203968-A1 (AU)
Title: Macrocycles with hetrocyclic p2' groups as factor xia inhibitors
Inventor: CORTE JAMES R
IPC: C07D471/08
Filed: 2021-06-15
Abstract: The present invention provides compounds of Formula (I): 
X Y 
0 B 
R7 N R~AA 
G1 N 
or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the 
5 variables are as defined herein. These compounds are selective factor XIa inhibitors or 
dual inhibitors of FXIa and plasma kallikrein. This invention also relates to 
pharmaceutical compositions comprising these compounds and methods of treating 
thromboembolic and/or inflammatory disorders using the same.
Patent AU-2021204605-A1 (AU)
Title: Systems, Devices, and Methods for Introducing Additives to a Pressurised Vessel
Inventor: DROMGOOL MATTHEW
IPC: C12C13/00
Filed: 2021-07-01
Abstract: An additive dispensing device for dispensing of additives into a pressurised vessel, more particularly 
a fermentation vessel of a brewing system, is disclosed. The device has a vessel body including a 
chamber, the chamber having a closed end and an open end. A pressure release means is provided 
between the chamber and atmosphere. A controllable valve positioned between the closed end and 
the open end, configured to selectively open and close a flow path between the closed end and the 
open end.
Patent AU-2021204829-A1 (AU)
Title: Optimized parent and path selection for battery powered devices within a wireless network
Inventor: OSTERLOH CHRISTOPHER LLOYD
IPC: H04W40/08
Filed: 2021-07-09
Abstract: OPTIMIZED PARENT AND PATH SELECTION FOR BATTERY POWERED 
DEVICES WITHIN A WIRELESS NETWORK 
ABSTRACT OF THE DISCLOSURE 
A wireless network includes nodes (e.g., 200) configured to implement an 
improved parent and path selection process to efficiently and reliably manage energy 
consumption of a battery powered device node. When a given node selects a path, 
the node transmits requests to multiple potential parent nodes. Each potential parent 
node transmits a metric that is indicative of the remaining battery life of the nodes in 
the path that includes the respective potential parent node. The given node then 
selects a parent node, and corresponding path, based on the metrics. More 
specifically, the given node selects a path, where at least one node on the selected 
path is less likely to prematurely exhaust the remaining battery life of the node, 
relative to the nodes in the other potential paths. As a result, the given node selects a 
path that optimizes battery consumption of the various battery powered nodes in the 
wireless network.
0.  
I IA 
K Iz 
-- - - - - -- I 
w~ 0I 
-U 
0 z I.  
-o - - - I u 
I-I 
lz0 _ 
Io ~ -co 
1I - - - - - - I 
--- - - - - - -- - - - - - -- - - - - - -i
Patent AU-2021204942-A1 (AU)
Title: Application of a reagent down-regulating circular gene expression in preparation of a drug to prevent and/or treat pulmonary fibrosis, and drug
Inventor: SONG XIAODONG
IPC: A61P11/00
Filed: 2021-01-04
Abstract: An application of a reagent down-regulating expression of circular RNA-0007535 in the preparation of a drug to prevent and/or treat pulmonary fibrosis and a drug down-regulating expression of circular RNA-0007535, in the technical field of drug preparation. Provided in the present invention is an application of the reagent down-regulating expression of circular RNA-0007535 in the preparation of a drug to prevent and/or treat pulmonary fibrosis, a nucleotide sequence of circular RNA-0007535 being as shown in SEQ ID NO. 1. A drug obtained by means of preparation with the reagent down-regulating expression of circular RNA-0007535 can prevent and/or treat pulmonary fibrosis, the circular RNA-0007535 being capable of acting as a potential molecule and drug target for treatment of pulmonary fibrosis.
Patent AU-2021212006-A1 (AU)
Title: Modifications and uses of conotoxin peptides
Inventor: POSAKONY JEFFREY JERARD
IPC: A61K38/10
Filed: 2021-08-03
Abstract: The present disclosure describes analog conotoxin peptides of the a-conotoxin peptide RgA.  
These analog conotoxin peptides block the a9al0 subtype of the nicotinic acetylcholine receptor 
(nAChR) and can be used for treating pain and inflammation including inflammatory pain, 
cancer related pain, and neuropathic pain. The RgIA analogs described in the present invention 
include a variety of sequence modifications and chemical modifications that are introduced to 
improve the drug-like characteristics of RgIA analogs and thereby increase their therapeutic 
value.
Patent AU-2021228499-A1 (AU)
Title: Antigen-presenting extracellular vesicles, composition containing same, and methods for production thereof
Inventor: HANAYAMA Rikinari
IPC: A61K35/15
Filed: 2021-03-01
Abstract: To provide extracellular vesicles capable of satisfactorily activating, etc., antigen-specific T cells.　Provided are said antigen-presenting extracellular vesicles that present an antigen-presenting MHC molecule and a T-cell-stimulating cytokine extramembranously.
Patent AU-2021229611-A1 (AU)
Title: Tasquinimod or a pharmaceutically acceptable salt thereof for use in combination therapy
Inventor: NEFEDOVA YULIYA
IPC: A61K31/47
Filed: 2021-03-03
Abstract: A combination comprising tasquinimod, or a pharmaceutically acceptable salt thereof, and at least one further compound selected from a proteasome inhibitor, an immunomodulatory imide, and an antibody, for use as a in the treatment of multiple myeloma. A kit comprising tasquinimod and a package insert with instructions for using tasquinimod in combination with at least one further compound selected from a proteasome inhibitor, an immunomodulatory imide, and an antibody, to treat multiple myeloma in an individual. Tasquinimod for use in the treatment of multiple myeloma, in combination with a further compound selected from a proteasome inhibitor, an immunomodulatory imide, and an antibody.
Patent AU-2021258205-A1 (AU)
Title: Antiviral structurally-stabilized ACE2 helix 1 peptides and uses thereof
Inventor: WALENSKY LOREN D
IPC: A61K38/55
Filed: 2021-04-22
Abstract: Disclosed herein are structurally stabilized peptides of ACE2 helix 1 useful for diagnosing, preventing, and treating coronavirus infection by targeting the receptor binding domain of SARS-CoV-2 and thereby blocking its interaction with the human ACE2 receptor, which is involved in coronavirus infection and pathogenesis.
Patent AU-2021263903-A1 (AU)
Title: Tap to pay credit bill
Inventor: RULE JEFFREY
IPC: G06F21/35
Filed: 2021-04-29
Abstract: Various embodiments are directed to enhancing a card payment experience by a single tap of a contactless card to a user computing device. In examples, the single tap of the card may be preconfigured to cause automatic payment of a predefined amount toward a card balance. If the single tap is not preconfigured to mean automatic card payment, the user may be presented with a notification and various payment amount options, which the user can select to pay toward the card balance.
Patent AU-2021265350-A1 (AU)
Title: A system for acquiring ultrasound images of internal body organs
Inventor: SONNENSCHEIN ELAZAR
IPC: A61B8/00
Filed: 2021-04-25
Abstract: A system for acquiring ultrasound images of internal body organs comprises a scanner and at least one inertial measurement unit (IMU) associated therewith, wherein the system is configured to issue instructions to the operator of the system that allow scans to be performed also by persons not trained for ultrasound scanning including the patient themselves, and wherein when the scans are performed by untrained operators, the scans are transmitted to a remote location for analysis by a healthcare professional.
Patent AU-2021273661-A1 (AU)
Title: Current carrying test system, transient-state current carrying test method, and steady-state current carrying test method for three-phase coaxial high-temperature superconducting cable
Inventor: WEI DEFU
IPC: G01R31/08
Filed: 2021-08-18
Abstract: The present disclosure provides a current carrying test system, and a transient-state current 
carrying test method, and a steady-state current carrying test method for a three-phase coaxial 
high-temperature superconducting cable. The test system includes an electric induction voltage 
regulator, a low-voltage large-current generator, a closing circuit breaker, a current transformer 
(CT), a disconnector, a three-phase coaxial superconducting cable system, a grounding circuit 
breaker, an analog load, a grounding switch, a console, and a comprehensive measurement, 
control and protection apparatus. In the above manner, in addition to providing a fault-specific 
transient-state current carrying test system for a three-phase coaxial superconducting cable, the 
present disclosure also provides a fault-specific transient-state current carrying test method for a 
three-phase coaxial superconducting cable, to ensure that the whole test system allows 
conducting a long-time large-current steady-state current carrying test and an instantaneous 
strong-current transient-state current carrying test on the three-phase coaxial high-temperature 
superconducting cable, and synchronously monitors operation parameters of the cable. The 
present disclosure is safe, reliable, and widely applicable, and has controllable parameters.  
4 56 
FIGL1
Patent AU-2021287299-A1 (AU)
Title: Cyclic peptide inhibitors of PSD-95 and uses thereof
Inventor: BALBOA JAVIER RODRIGUEZ
IPC: C07K14/435
Filed: 2021-06-11
Abstract: The present invention relates novel cyclic peptides which can act as inhibitors of protein-protein interactions, specifically by inhibiting the PDZ2 domain of PSD-95, as well as their use in treatment of excitotoxic-related diseases and neuropathic pain.
Patent AU-2021290345-A1 (AU)
Title: Metasurfaces for redirecting light and methods for fabricating
Inventor: PEROZ CHRISTOPHE
IPC: G02B6/00
Filed: 2021-12-23
Abstract: of the Disclosure 
A display system comprising a stack of waveguides, wherein each waveguide of the 
stack of waveguides comprises: a light incoupling optical element disposed on a surface of the 
waveguide, the light incoupling optical element comprising a multilevel metasurface 
comprising a plurality of spaced apart protrusions having a pitch and formed of a first optically 
transmissive material, a second optically transmissive material disposed over and between the 
spaced apart protrusions and a light outcoupling optical element disposed on a surface of the 
waveguide, the light outcoupling optical element configured to output light with wavefront 
divergence corresponding to a depth plane. The associated multilevel metasurface of a first of 
the waveguides is configured to redirect light of different ranges of wavelengths than the 
associated multilevel metasurface of a second of the waveguides, wherein the light outcoupling 
optical elements of the first and the second waveguides are configured to output light with 
wavefront divergence corresponding to a same depth plane, and wherein the light outcoupling 
optical elements of some others of the stack of waveguides are configured to output light with 
wavefront divergence corresponding to one or more different depth planes.
Patent AU-2021309295-A1 (AU)
Title: Pharmaceutical composition containing cerium compound as active ingredient
Inventor: KAWAGUCHI TSUNETAKA
IPC: A61K47/18
Filed: 2021-04-30
Abstract: The primary problem of the present invention is to provide a novel pharmaceutical composition. The present invention relates to a pharmaceutical composition containing a cerium compound as an active ingredient.
Patent AU-2021323772-A1 (AU)
Title: Methods, apparatus, storage mediums, and electronic devices for information exchange
Inventor: ZHANG XUDONG
IPC: G06Q10/02
Filed: 2021-08-03
Abstract: An information exchange method and apparatus, a storage medium, and an electronic device. After receiving task information of a task to be processed, a task processing terminal sends its own position. A task issuing terminal controls a display apparatus to render and display a position modification control corresponding to the task and, in response to the control being triggered, displays a modification page to detect an input operation. When a specific input operation is detected, the task issuing terminal determines corresponding position information and sends to a server position modification information determined on the basis of the position information. Thus, the server acquires the task information and, when the task processing state of the task is unprocessed, sends to the task processing terminal a position modification prompt and the position modification information, such that the task processing terminal modifies the starting position of the task on the basis of the position information. The possibility of tasks being cancelled is reduced and the rate of utilisation of task processing resources is increased.
Patent AU-2021355437-A1 (AU)
Title: Cullet and cullet water handling system
Inventor: RAUSCH PHILIP
IPC: C03B9/40
Filed: 2021-09-30
Abstract: A glassware manufacturing system 10, waste handling system 12, and method are disclosed. The glassware manufacturing system 10, in accordance with one aspect of the disclosure, comprises an architectural installation 14 having a forming floor 18 and no basement beneath the forming floor 18; a glassware forming machine 16 carried on the forming floor 18; a molten glass feeder 24 configured to provide molten glass 26 to the glassware forming machine 16; and a glassware manufacturing waste handling system 12 including a sump pit 28 in the forming floor 18; and a waste liquid trench 22 substantially surrounding the glassware forming machine 16 and flowing to the sump pit 28. Also, a cullet material handler 30 and/or a molten waste glass sluice 56 may be configured to receive molten glass 26 and unused molten glass streams from the molten glass feeder 24 and hot glassware rejects from the glassware forming machine 16.
Patent AU-2021376268-A1 (AU)
Title: Therapeutic methods and compositions for treating pancreatic cancer using devimistat
Inventor: LUTHER SANJEEV
IPC: A61K31/20
Filed: 2021-11-03
Abstract: The invention provides methods, compositions, and medical kits for treating pancreatic cancer using (i) devimistat in combination with (ii) modified FOLFIRINOX.
Patent AU-2021377556-A1 (AU)
Title: Sprayable fire-resistant composition and production method therefor
Inventor: KOMATSUBARA KIYOYUKI
IPC: C04B35/66
Filed: 2021-10-13
Abstract: A sprayable fire-resistant composition according to the present invention includes primarily magnesia-spinel brick waste and magnesia feedstock as fire-resistant feedstock, wherein the magnesia-spinel brick waste content is 10 mass% or more relative to 100 mass% of the fire-resistant feedstock, and the magnesia feedstock content is from 0 mass%-90 mass% relative to 100 mass% of the fire-resistant feedstock.
Patent AU-2021379280-A1 (AU)
Title: Novel system for solubilising fat-soluble organic sun filters
Inventor: DROMIGNY HÉLÈNE
IPC: A61K8/35
Filed: 2021-11-10
Abstract: The present invention relates to a cosmetic or dermatological composition in the form of an emulsion, comprising: (a) a fat-soluble photoprotective system consisting of one or more fat-soluble UV filter(s) selected from: (i) hexyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate, (ii) 2,4-bis[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-6-(4-methoxyphenyl)-1,3,5-triazine, (iii) butyl methoxydibenzoylmethane, (iv) ethylhexyl triazone, and (v) diethylhexyl butamido triazone; (b) a solubilising system of the fat-soluble photoprotective system (a), comprising C12-C15 alkyl benzoate in a quantity greater than or equal to 80% by weight, preferably greater than or equal to 90% by weight, relative to the total weight of the solubilising system; and (c) one or more particulate organic UV filters, which are in particular hydro-dispersed and are selected from: (vi) 5,6,5',6'-tetraphenyl-3,3'-(1,4-phenylene)-bis[1,2,4]triazine, (vii) methylene bis-benzotriazolyl tetramethylbutylphenol, (viii) tris-biphenyl triazine; characterised in that: - the fat-soluble photoprotective system (a) constitutes between 3% and 19% by weight, preferably between 5% and 15% by weight, relative to the total weight of the composition; - and - the solubilising system (b) constitutes between 15% and 30% by weight, relative to the total weight of the composition; the composition not comprising ethylhexyl salicylate, octocrylene, ethylhexyl methoxycinnamate, isoamyl methoxylcinnamate, homosalate, para-aminobenzoic acid (PABA), octyl dimethyl PABA, 3-methylbenzylidene 30 camphor, 4-methylbenzylidene camphor, benzophenone-3 and/or benzophenone-4.
Patent AU-2021444032-A1 (AU)
Title: Water electrolysis stack for generating hydrogen and oxygen from water
Inventor: HÖLLER STEFAN
IPC: C25B1/04
Filed: 2021-05-03
Abstract: The water electrolysis stack (0) is used to generate hydrogen and oxygen from water and has a number of PEM-type electrolysis cells (2) arranged to form a cell stack (1). A first channel for supplying water, a second channel for removing water and the product gas oxygen and a third channel for removing the product gas hydrogen pass through the cell stack (1). The electrolysis cells (2) have a catalytically coated proton exchange membrane which adjoins a bipolar plate via a sealing frame on the hydrogen side, the rear face of which bipolar plate in turn rests on the membrane of the adjacent cell on the oxygen side. The bipolar plate is designed as a sintered component and has a planar metal plate on which a metal frame is situated that accommodates a channel-forming element in a central recess, and thereabove a second metal frame having a central recess and a porous transport layer incorporated therein. The channels of the channel-forming element connect the first and the second channel of the cell stack.
Patent AU-2021455367-A1 (AU)
Title: Plated Steel
Inventor: TOKUDA KOHEI
IPC: C23C2/06
Filed: 2021-07-09
Abstract: A plated steel material which has a plating layer on the surface of a steel material, and which is characterized by satisfying formula 1 (0 ≤ Cr + Ti + Ni + Co + V + Nb + Cu + Mn ≤ 0.25) and formula 2 (0 ≤ Sr + Sb + Pb + B + Li + Zr + Mo + W + Ag + P ≤ 0.50), and also satisfying formula 3 (I(MgZn
Patent AU-2022200173-A1 (AU)
Title: Subsea biofouling preventer device
Inventor: CORDOBA AYMER YEFERSON MATURANA
IPC: B08B17/00
Filed: 2022-01-12
Abstract: SUBSEA BIOFOULING PREVENTER DEVICE 
ABSTRACT 
The present invention relates to a high-intensity ultraviolet light emitting diodes (UV
LED) device 1 for preventing biofouling formation in a system for subsea operation of 
a target fluid. Further, the present invention discloses such device for coupling or 
integration into a subsea treatment system and to a process using such device.  
FIGURE 1
WO 2019/042863 PCT/EP2018/072781 
1/4 
Figure 1: 
1 
2 
8 10 
6 4 
Figure 2: 
6 
Figure 3: 
8 
10 
7' 
6 12 
4 
(a)
Patent AU-2022202347-A1 (AU)
Title: Libraries of Nucleic Acids and Methods for Making the Same
Inventor: JACOBSON JOSEPH
IPC: C40B50/00
Filed: 2022-04-07
Abstract: Methods for designing and producing non-random libraries of nucleic acids are presented.  
In particular, synthesis of non-random libraries by multiplexed polynucleotide synthesis is 
utilized. Each library member may encode a promoter, ribosomal binding site and 
polypeptide.
Patent AU-2022207244-A1 (AU)
Title: Nucleic acid molecule containing incorporated gene encoding fused protein of ligand and protein having physiological activity
Inventor: KINOSHITA MASAFUMI
IPC: C12N15/62
Filed: 2022-01-11
Abstract: The present invention provides a nucleic acid molecule that contains a gene encoding a fused protein of a ligand and a protein having a physiological activity, said nucleic acid molecule being to be used for expressing the fused protein in a cell, a tissue or in vivo. The present invention also provides the nucleic acid molecule containing a gene encoding the aforesaid fused protein, said nucleic acid molecule being in the form of a plasmid, encapsulated in a recombinant viral virion, or encapsulated in a liposome or a lipid nanoparticle. Further, the present invention pertains to the use of the nucleic acid molecule, which contains a gene encoding the aforesaid fused protein, as a medicine.
Patent AU-2022212231-A1 (AU)
Title: Method for transposase mediated spatial tagging and analyzing genomic dna in a biological sample
Inventor: STAHL PATRIK
IPC: C12Q1/6806
Filed: 2022-01-07
Abstract: The present disclosure relates to materials and methods for spatially analyzing nucleic acids fragmented with a transposase enzyme in a biological sample.
Patent AU-2022227150-A1 (AU)
Title: Regeneration and multiple use of depth filters
Inventor: FALKENSTEIN ROBERTO
IPC: C07K1/34
Filed: 2022-02-21
Abstract: Herein is reported a method for the purification or production of a therapeutic polypeptide using the same depth filter multiple times, i.e. a depth filter which has been used before and has been regenerated. Reported herein is a method for purifying or producing a therapeutic polypeptide, characterized in that the method comprises the following steps: a) filtering an aqueous composition containing said therapeutic polypeptide and impurities through a depth filter, recovering the flow-through and thereby obtaining said purified therapeutic polypeptide, b) contacting said depth filter with a regeneration solution and thereby regenerating the depth filter, and c) repeating steps a) and b) one or more times.